UPC APP 43889/2024

—·EP3167888: TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT

Case details: Status
—
Action
Procedural application
Category
Other Procedural
Parties: Claimants
Alexion Pharmaceuticals, Inc.
Reps: Elena Hennecke (Freshfields Bruckhaus Deringer)
Respondents
Amgen Technology (Ireland) Unlimited Company
Amgen N.V.
Amgen GmbH (Germany)
Amgen GmbH (Austria)
Amgen AB
Amgen S.A.S.
Amgen s.r.l.
Amgen Biofarmacêutica Lda.
Amgen Zdravila D.O.O.
Reps: Tilman Müller-Stoy (Bardehle Pagenberg)
Division: Court of Appeal
Judges: Klaus Grabinski · President of the Court of Appeal
Peter Blok · Legally qualified judge and judge-rapporteur
Emanuela Germano · Legally qualified judge
Technology: Organic Chemistry
Language: —
First decided: Jul 30, 2024

Decisions

2024-07-30
Appeal decisionGeneric application
The Court of Appeal rejected Alexion Pharmaceuticals' request to expedite the appeal against the Hamburg Local Division's refusal to grant provisional measures against Amgen, holding that the circumstances were not sufficiently urgent to justify shortening the time period for the respondents to lodge their statement of response.
Legal issues:Expedition of appealR.9.3(b) RoPShortening of deadlinesProvisional measures appealR.225(e) RoP

Documents